+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ampio Pharmaceuticals Inc - logo

Ampio Pharmaceuticals is a biopharmaceutical company that focuses on developing therapies for the treatment of prevalent inflammatory conditions in the United States. Ampio has received over 180 patents throughout the world, with hundreds more pending. The company's leading product candidates are Ampion and Optina. Amption is a intra-articular injection being studied for the treatment of osteoarthritis of the knee. Optina is an oral agent being studied for the treatment of diabetic macular edema. Ampio is headquartered in Englewood, Colorado.

From
From
From
From
Osteoarthritis Pain - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoarthritis Pain - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 233 pages
From
Calcitonin Gene Related Peptide - Pipeline Review, H2 2020 - Product Thumbnail Image

Calcitonin Gene Related Peptide - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 96 pages
From
From
Diabetic Macular Edema - Pipeline Insight, 2020 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
Wet Macular Degeneration - Pipeline Insight, 2020 - Product Thumbnail Image

Wet Macular Degeneration - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
From
Diabetic Macular Edema - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 319 pages
From
From
Neuroblastoma - Pipeline Insight, 2020 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
From
Global Osteoarthritis Pain Market 2016-2020 - Product Thumbnail Image

Global Osteoarthritis Pain Market 2016-2020

  • Report
  • May 2016
  • 97 pages
From
From
From
Loading Indicator
adroll